Exploring Selective Sodium Channel Inhibition for the Management of Acute Pain
October 20 | 12:00 pm – 1:00 pm
Join this session for a comprehensive clinical overview of suzetrigine, a non-opioid pain signal inhibitor used in the management of moderate-to-severe acute pain, including postoperative pain. The session will explore suzetrigine’s mechanism of action and findings from clinical studies evaluating it, and will then discuss real-world experiences in using suzetrigine in clinical practice.

Massachusetts Health & Hospital Association